Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news.

The June 2020 email newsletter highlights COVID-19 resources from Mayo Clinic:

• Latest news on the pandemic
• Why some patients may benefit from expedited breast cancer treatments
• Why patients with lung cancer in a COVID-19 era need to keep their treatment

Both email and online June 2020 editions feature:

• Director's message: Our commitment to patients remains unchanged
  Dr. Fonseca offers a message of hope and safety as Mayo Clinic Cancer Center adjusts to the coronavirus.
• COVID-19 accelerates telemedicine use in oncology practices
  Mayo Clinic is expanding its technology to provide more virtual care services for higher-risk patients.
• Mayo Clinic researchers study blood test to detect multiple cancers
  Methylation-based screening offers a step forward in early detection of more than 50 types of cancer.
• Olanzapine may help control nausea, vomiting in advanced cancer
  Study participants reported improvements in vomiting, appetite and well-being while taking the drug.
• Tumor-infiltrating lymphocytes may offer clue to colorectal cancer survival
  Study findings show that using routine tissue sections could help guide recommendations for chemotherapy.
• Researchers ID microbiome signature in endometrial cancer
  Their study shows that post-menopause, obesity and high vaginal pH alter the microbiome and increase risk.

Subscribe.

Tags: cancer, cancer research, Mayo Clinic Cancer Center, News